Cargando…
Predominantly defective CD8(+) T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients
BACKGROUND: Although mRNA vaccines have overall efficacy preventing morbidity/mortality from SARS-CoV-2 infection, immunocompromised persons remain at risk. Antibodies mostly prevent early symptomatic infection, but cellular immunity, particularly the virus-specific CD8(+) T cell response, is protec...
Autores principales: | Taus, Ellie, Shino, Michael Y., Ibarrondo, F. Javier, Hausner, Mary Ann, Hofmann, Christian, Yang, Otto O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248978/ https://www.ncbi.nlm.nih.gov/pubmed/37291575 http://dx.doi.org/10.1186/s12967-023-04234-z |
Ejemplares similares
-
Dominant CD8(+) T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination
por: Taus, Ellie, et al.
Publicado: (2022) -
Persistent memory despite rapid contraction of circulating T Cell responses to SARS-CoV-2 mRNA vaccination
por: Taus, Ellie, et al.
Publicado: (2023) -
Human cytomegalovirus-specific CD4+ and CD8+ T-cells in organ transplant recipients
por: Lilleri, D., et al.
Publicado: (2006) -
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
por: Ibarrondo, F. Javier, et al.
Publicado: (2020) -
Distinct aging profiles of CD8(+) T cells in blood versus gastrointestinal mucosal compartments
por: Dock, Jeffrey, et al.
Publicado: (2017)